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SesterterpenesAbstract Aralia species are used in traditional medicine to treat rheumatic arthritis, nephritis, lum-
bago, lameness, gastritis, inﬂammation and diabetes mellitus. Phytochemical investigation of the
roots of Aralia cachemirica Decne (Araliaceae) collected from the Aharbal region of Kashmir affor-
ded four new phytoconstituents identiﬁed as n-tetracont-19-enoic acid (1), 4a,4b,8b,10b,13b,17b-
hexamethyl perhydrophenanthrenyl-3b-n-decanoate (3), tetrahydrocontinentalic acid (4) and
1b,4a,4b-trimethyl-6-(10,14,18-trimethyl-tridec-6-enyl)-cyclohexane-4b-ol (5) along with the known
compounds continentalic acid (2), maltose (6) and sucrose (7). The structures of these phytoconstit-
uents have been elucidated on the basis of spectral data analysis.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Aralia cachemirica Decne (Araliaceae), known as Khoree and
Banakhor, is a perennial aromatic lax shrub, up to 3 m tall,
distributed in Afghanistan, Tibet, Kashmir, Himachal
Pradesh, Uttarakhand and Sikkim (Pusalkar, 2009). Aralia
species are used in traditional medicine to treat gastritis, rheu-
matic arthritis, inﬂammation, nephritis and diabetes mellitus
(Oh et al., 2009; Liu et al., 2000). It is eaten by goats as a nutri-
ent (Anon., 2003). A. cachemirica yielded aralosides (George
et al., 1984), b-sitosterol (Anon., 2003), sugars (Bhat et al.,2010), essential oil (Shawl et al., 2009; Verma et al., 2010)
and continentalic acid (Sharma et al., 2011). The plant showed
hyperglycaemic (Bhat et al., 2005) and antibacterial (Sangwan
et al., 2008) activities. This manuscript describes the isolation
and characterization of new fatty acids, tetraterpinolide and
diterpenic acid from the roots of A. cachemirica.2. Materials and methods
2.1. General
The melting points were determined on a Perﬁt apparatus and
are uncorrected. The IR spectra were recorded on KBr pellet
using a jasco FT/IR-5000 instrument (FTS 135, Hongkong).
The 1H NMR (400 MHz) and 13C NMR (100 MHz) spectra
were scanned on DRX-400 Avance 400 MHz spectrometer
(Bruker-Biospin, Rheinstetten, Germany) using CDCl3 as
solvent and TMS as internal standard. FAB-MS were
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MA, USA). Column (450 · 4 · 0.2 cm) chromatography was
performed on silica gel (60–120 mesh, Qualigens, Mumbai, In-
dia) and thin layer chromatography on silica gel G-coated
TLC plates (Merck). Spots were visualized by exposure to io-
dine vapours, UV radiation and by spraying reagents.
2.2. Plant material
The dried roots of A. cachemirica were collected from the
Aharbal region of Kashmir and was authenticated by Dr.
A.R. Naqshi, the Department of Taxonomy, University of
Kashmir, Srinagar with a voucher specimen No. PS/UKS/
AR-1 and was deposited in herbarium for future reference in
the Department of Pharmaceutical Sciences, University of
Kashmir, Srinagar.
2.3. Extraction and isolation
The air dried roots (2.5 kg) were coarsely powdered and ex-
tracted exhaustively in a Soxhlet apparatus with methanol
for 72 h. The methanolic extract was concentrated under re-
duced pressure to obtain a dark brown viscous mass (210 g).
Small portion of extract was analyzed chemically to determine
the presence of different chemical constituents. The concen-
trated extract (150 g) was dissolved in methanol (250 ml) and
adsorbed on silica gel (60–120 mesh) for column chromatogra-
phy. The slurry was air dried and chromatographed over silica
gel column packed in petroleum ether. The column was eluted
successively with petroleum ether, mixture of petroleum ether
and chloroform (9:1, 3:1, 1:1, and 1:3), pure chloroform and
ﬁnally the mixture of chloroform and methanol (99:1, 97:3,
19:1, 23:2, 9:1, 3:1, and 1:1, 1:3). Various fractions were col-
lected separately and matched by TLC to check homogeneity.
Similar fractions having same Rf values were combined and
crystallized. The isolated compounds were recrystallized to
get pure compounds. The following compounds were isolated:
2.4. n-Tetracont-19-enoic acid (1)
Elution of the column with petroleum ether gave colourless
amorphous powder of 1, recrystallized from acetone–methanol
(1:1), yield 0.36%, m.p. 54–55 C, Rf 0.3 (petroleum ether–
chloroform, 9:1); IR mmax (KBr): 3300, 2950, 2843, 1690,
1643, 1410, 1315, 1280, 1130, 721 cm1; 1H NMR (CDCl3):
d 5.03 (1H, m, w1/2 = 9.8 Hz, H-19), 5.00 (1H, m, w1/2 =
9.8 Hz, H-20), 2.14 (2H, t, J= 7.1 Hz, H2-2), 2.01 (2H, m,
H2-18), 1.98 (2H, m, H2-21), 1.52 (4H, m, 2·CH2), 1.29
(62H, brs, 31·CH2), 0.91 (3H, t, J= 6.5 Hz, Me-40); 13C
NMR (CDCl3): d 180.06 (C-1), 122.31 (C-19), 115.02 (C-20),
55.20 (C-2), 40.17 (CH2), 39.52 (CH2), 37.61 (CH2), 35.42
(CH2), 31.87 (CH2), 28.12 (CH2), 29.45 (28·CH2), 22.56
(CH2), 18.51 (Me-40); +ve FAB MS m/z (rel. int): 591
[M+H]+ (C40H79O2) (12.3), 283 (9.8), 307 (19.5).
2.5. Continentalic acid (2)
Elution of the column with petroleum ether–chloroform (9:1)
afforded colourless crystals of 2, recrystallized from methanol,
yield 1.36%; m.p. 159–160 C, IR mmax (KBr): 3280, 1693,
cm1; 1H NMR (CDCl3): d 6.55 (1H, brs, H-14), 5.73 (1H,
dd, J= 9.9 Hz, 7.2 Hz, H-15), 5.14 (1H, brs, H2-16a), 4.92(2H, d, J= 12.6 Hz, H2-16b), 1.25 (3H, brs, Me-19), 1.01
(3H, brs, Me-20), 0.65 (3H, brs, Me-17); 13C NMR (CDCl3):
d 38.51 (C-1), 19.22 (C-2), 36.40 (C-3), 44.04 (C-4), 56.09 (C-
5), 29.21 (C-6), 35.78 (C-7), 137.93 (C-8), 50.51 (C-9), 37.90
(C-10), 29.71 (C-11), 29.35 (C-12), 39.15 (C-13), 127.96 (C-
14), 147.14 (C-15), 112.91 (C-16), 24.08 (C-17), 184.83 (C-
18), 19.56 (C-19), 13.79 (C-20); +ve FAB MS m/z (rel. int):
303 [M+H]+ (C20H31O2) (11.2).
2.6. Cachemiridiol (3)
Elution of column with petroleum ether–chloroform (9:1)
afforded colourless crystals of 3, recrystallized from acetone–
methanol (1:1), yield 0.36%, Rf 0.4 (petroleum ether–benzene,
17:3), m.p. 85–86 C, IR mmax (KBr): 3410, 2925, 2872, 1725,
1642, 1430, 1210, 1145, 1052 cm1; 1H NMR (CDCl3): d
5.26 (1H, d, J= 5.6, H-6), 5.07 (1H, m, H-11), 4.25 (1H, dd,
J= 5.5, 9.6 Hz, H-3a), 3.25 (2H, t, J= 9.5 Hz, H2-19), 2.53
(2H, t, J= 7.2 Hz, H2-2
0), 2.27 (2H, m, H2-7), 2.18 (2H, m,
H2-12), 1.58 (2H, m, H2-2), 1.98 (1H, m, H-14), 1.85 (2H, m,
H2-1), 1.71 (1H, m, H-13), 1.68 (1H, m, H-17), 1.63 (2H, m,
H2-15), 1.58 (2H, m, CH2), 1.54 (4H, m, 2·CH2), 1.42 (16H,
brs, 8·CH2), 1.19 (3H, brs, Me-22), 1.02 (3H, d, J= 6.2 Hz,
Me-24), 0.95 (3H, d, J= 6.5 Hz, Me-25), 0.88 (3H, brs, Me-
20), 0.83 (3H, t, J= 6.1 Hz, Me-100), 0.80 (3H, brs, Me-21),
0.68 (3H, brs, Me-23); 13C NMR (CDCl3): d 45.07 (C-1),
34.18 (C-2), 69.94 (C-3), 42.01 (C-4), 140.92 (C-5), 120.22
(C-6), 39.22 (C-7), 56.28 (C-8), 137.82 (C-9), 38.36 (C-10),
127.46 (C-11), 38.96 (C-12), 49.52 (C-13), 55.28 (C-14), 35.28
(C-15), 33.48 (C-16), 50.52 (C-17), 33.28 (C-18), 61.52 (C-
19), 25.35 (C-20), 20.46 (C-21), 18.95 (C-22), 18.65 (C-23),
20.48 (C-24), 21.19 (C-25), 172.12 (C-10), 31.24 (C-20), 28.96
(C-30), 28.96 (C-40), 28.96 (C-50), 28.96 (C-60), 28.52 (C-70),
28.52 (C-80), 22.34 (C-90), 14.21 (C-100); +ve FAB MS m/z
(rel. int): 529 [M+H]+ (C35H61O3) (9.3), 373 (22.15), 155
(12.5).
2.7. Tetrahydrocontinentic acid (4)
Elution of column with chloroform–methanol (49:1) afforded
colourless amorphous powder of 4, recrystallized from ace-
tone–methanol (1:1), yield 1.26%, Rf 0.5 (chloroform–ethyl
acetate, 4:1), m.p. 115–116 C, IR mmax (KBr): 3410, 2926,
2850, 1697, 1539, 1470, 1370, 1250, 1120 cm1; 1H NMR
(CDCl3): d 2.16 (1H, m, H-5b), 1.98 (2H, m, H2-1), 1.86
(2H, m, H2-2), 1.79 (2H, m, H2-3), 1.71 (2H, m, H2-14), 1.68
(2H, m, H2-7), 1.53 (1H, m, H-9), 1.47 (1H, m, H-8), 1.35
(2H, m, H2-6), 1.32 (3H, brs, Me-19), 1.29 (2H, m, H2-12),
1.23 (2H, m, H2-11), 1.21 (2H, m, H2-15), 1.16 (3H, brs, Me-
20), 1.14 (3H, brs, Me-17), 0.85 (3H, t, J= 6.3 Hz, Me-16);
13C NMR (CDCl3): d 41.20 (C-1), 23.60 (C-2), 39.35 (C-3),
47.51 (C-4), 56.81 (C-5), 28.73 (C-6), 37.25 (C-7), 55.05 (C-
8), 55.86 (C-9), 38.73 (C-10), 25.96 (C-11), 36.60 (C-12),
42.50 (C-13), 44.31 (C-14), 21.37 (C-15), 14.77 (C-16), 28.16
(C-17), 179.05 (C-18), 18.25 (C-19), 17.39 (C-20); +ve FAB
MS m/z (rel. int): 307 [M+H]+ (C20H35O2) (18.3).
2.8. Araliasesterterpenol (5)
Elution of column with chloroform–methanol (19:5) afforded
colourless crystals of 5, recrystallized from chloroform–methanol
(1:1), yield 0.15%, Rf 0.25 (toluene–ethyl acetate, 4:1), m.p. 218–
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1080 cm1; 1H NMR (CDCl3): d 5.13 (1H, m, H-7), 3.52 (1H,
dd, J= 5.1, 8.5 Hz, H-4a), 2.50 (1H, m, H-1), 2.26 (2H, m, H2-
8), 2.18 (2H, m, H2-3), 2.01 (2H, m, H2-2), 1.77 (2H, m, H2-3),
1.71 (1H, m, H-10), 1.62 (1H, m, H-14), 1.58 (1H, m, H-18),
1.52 (6H, brs, H2-9, H2-11, H2-12), 1.25 (8H, brs, H2-13, H2-15,
H2-16, H2-17), 1.23 (3H, brs, Me-21), 1.21 (3H, brs, Me-22),
1.11 (3H, d, J= 6.1 Hz, Me-20), 0.96 (3H, d, J= 6.3 Hz, Me-
23), 0.93 (3H, d, J= 6.0 Hz, Me-24), 0.88 (3H, d, J= 6.5 Hz,
Me-19), 0.83 (3H, d, J= 6.1 Hz, Me-25); 13C NMR (CDCl3): d
42.63 (C-1), 13.95 (C-2), 13.76 (C-3), 71.08 (C-4), 55.16 (C-5),
140.63 (C-6), 127.13 (C-7), 41.36 (C-8), 31.15 (C-9), 36.38 (C-
10), 30.88 (C-11), 29.16 (C-12), 29.12 (C-13), 37.46 (C-14),
28.43 (C-15), 28.37 (C-16), 28.57 (C-17), 33.39 (C-18), 17.63 (C-
19), 21.89 (C-20), 27.16 (C-21), 24.09 (C-22), 21.63 (C-23),
15.02 (C-24), 18.56 (C-25); +ve FAB MS m/z (rel. int): 365
[M+H]+ (C25H49O) (5.5).
2.9. Maltose (6)
Elution of the column with chloroform–methanol (9:1) gave
colourless crystals of 6, yield 0.12%, recrystallized from aque-
ous alcohol, m.p. 102–103 C, Rf 0.40 (n-butanol–acetone–
pyridine–water, 10:10:5:5; v/v); +ve FAB MS m/z (rel. int):
343 [M+H]+ (C12H23O11) (1.7).
2.10. Sucrose (7)
Further elution of the column with chloroform–methanol (9:1)
yielded colourless crystals of 7, yield 0.36%, recrystallized
from methanol, m.p. 161–164 C, Rf 0.20 (n-butanol–
acetone–pyridine–water, 10:10:5:5; v/v); +ve FAB MS m/z
(rel. int): 343 [M+H]+ (C12H23O11) (2.1).
3. Results and discussion
Compound 1 was obtained as a colourless amorphous powder
from petroleum ether eluents. It yielded effervescence with so-
dium bicarbonate and showed characteristic IR absorption
bands for carboxylic group (3300, 1690 cm1), unsaturation
(1643 cm1) and long aliphatic chain (721 cm1). Its mass
spectrum showed a molecular ion peak at m/z 591 [M+H]+
consistent with the molecular formula of an unsaturated fatty
acid C40H79O2. The ion fragments generating at m/z 307
[CH3(CH2)19CH‚CH]
+ and 283 [M-307; (CH2)17COOH]
+
suggested the location of the vinylic linkage at C-19. The 1H
NMR spectrum displayed two one-proton multiplets at d
5.03 and 5.00 with half-width of 9.8 Hz each assigned to cis-
oriented vinylic H-19 and H-20 protons, respectively, a two-
proton triplet at d 2.14 (J= 7.1 Hz) ascribed to methylene
H2-2 protons adjacent to the carboxylic function, other meth-
ylene protons from d 2.01 to 1.29 and a three-proton triplet at
d 0.91 (J= 6.5 Hz) accounted for the terminal C-40 primary
methyl protons. The 13C NMR spectrum of 1 exhibited signals
for the carboxylic carbon at d 180.06 (C-1), vinylic carbons at d
122.31 (C-19) and 115.02 (C-20), methylene carbons between d
55.20 and 22.56 and methyl carbon at d 18.51 (C-40). The ab-
sence of any signal between d 5.00 and 2.14 in the 1H NMR
spectrum and between d 115.02 and 22.56 in the 13C NMR
spectrum ruled out any carbinol carbon in the molecule. The
1H–1H COSY spectrum of 1 showed a correlation of H-19 withH-20, H2-18 and H2-21. On the basis of these evidences the
structure of 1 has been characterized as n-tetracont-19-enoic
acid. This is a new fatty acid.
CH3 (CH2)19 CH=CH (CH2)17COOH
40 20 19 1
1 
Compound 3, named cachemiridiol, was obtained as a col-ourless crystalline mass from petroleum ether–chloroform (4:1)
eluents. Its IR spectrum showed characteristic absorption
bands for hydroxyl groups (3410 cm1), ester function
(1725 cm1) and unsaturation (1642 cm1). On the basis of
mass and 13C NMR spectra the molecular ion peak of 3 was
determined at m/z 529 [M+H]+ consistent with the molecular
formula of a sesterterpenic ester, C35H61O3. The ion peaks
arising at m/z 155 [CH3(CH2)8CO]
+ and 373 [M-155;
C25H43O2]
+ indicated that n-capric acid was esteriﬁed with a
tricyclic sesterterpenoid. The 1H NMR spectrum of 6 exhibited
a one-proton doublet at d 5.26 (J= 6.5 Hz) and a one-proton
multiplet at d 5.07 that were assigned to vinylic H-6 and H-11,
respectively. A one-proton doublet at d 4.25 (J= 5.5, 9.6 Hz)
and a two-proton triplet at d 3.25 (J= 9.5 Hz) were ascribed
to the oxygenated methine H-3a and hydroxymethylene H2-
19 protons, respectively. Four three-proton broad singlets at
d 1.19, 0.88, 0.80 and 0.68, two three-proton doublets at d
1.02 (J= 6.2 Hz) and 0.95 (J= 6.5 Hz) and a three-proton
triplet at d 0.83 (J= 6.1 Hz) were attributed correspondingly
to the tertiary methyl C-22, C-20, C-21 and C-23, secondary
methyl C-24 and C-25 and primary methyl C-100 protons, all
attached to saturated carbons. The other methine and methy-
lene protons resonated from d 2.53 to 1.24. The 13C NMR
spectrum of 3 displayed signals for ester carbon at d 172.12
(C-10), vinylic carbons at d 140.92 (C-5), 120.22 (C-6), 137.82
(C-9) and 127.46 (C-11), oxygenated methine carbons at d
69.94 (C-3), hydroxymethylene carbon at d 61.52 (C-19) and
methyl carbons from d 25.35 to 14.21. The 1H–1H COSY spec-
trum showed correlations of H-3 with H2-1, H2-2 and Me-20;
H-6 with H2-7 and Me-21; H-11 with H2-12 and H-13; and H2-
19 with H-17 and H2-18. The HMBC spectrum of 3 exhibited
interactions of C-5 with Me-20, Me-21, H-6 and H2-7; C-9
with Me-23, Me-22, H-11 and H2-12; C-1
0 with H-3 and H2-
20; and H2-19 with H2-18 and H-17. On the basis of these evi-
dences the structure of 3 has been characterized as
4a,4b,8b,10b,13b,17b-hexamethyl perhydrophenanthrenyl-3b-
n-decanoate. This is a new tricyclic sesterterpenic ester.
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Compound 4, named tetrahydrocontinentalic acid, was ob-
tained as a colourless amorphous powder from chloroform–
methanol (49:1) eluents. It produced effervescence with sodium
bicarbonate solution and showed IR absorption bands for
carboxylic group (3410, 1697 cm1). On the basis of mass
290 Z.A. Bhat et al.and 13C NMR spectra the molecular ion peak of 4 was estab-
lished at m/z 307[M+H]+ corresponding to the molecular for-
mula of a tricylcic diterpenic acid C20H35O2. The
1H NMR
spectrum of 4 exhibited three broad singlets at d 1.32, 1.16
and 1.14 and a triplet at d 0.85 (J= 6.3 Hz), all integrating
with three protons each, ascribed to the tertiary C-19, C-20
and C-17 and primary C-16 methyl protons, respectively.
The methine and methylene protons appeared between d 2.16
and 1.21. The 13C NMR spectrum of 4 displayed signals for
the carboxylic carbons at d 179.05 (C-18), methyl carbons at
d 14.77 (C-16), 28.16 (C-17), 18.29 (C-19) and 17.39 (C-20)
and methylene and methine carbons between d 56.81 and
21.37. The absence of any signal beyond d 2.16 in the 1H
NMR spectrum and between d 179.05 and 56.81 in the 13C
NMR spectrum suggested the saturated nature of the molecule
and ruled out the existence of any carbinol carbon. The 1H–1H
COSY spectrum of 4 showed correlations of Me-19 with H2-3
and H-5; Me-20 with H2-1, H-9 and H-8; and Me-17 with H2-
12, H-8, H2-14, H-15 and Me-16. The HMBC spectrum of 4
exhibited interactions of C-18 with H2-3, H-5 and Me-19;
and C-13 with H2-12, H2-14, Me-17, H2-15 and Me-16
0. On
the basis of the foregoing account the structure of 4 has been
























Compound 5, designated as araliasesterterpenol, was ob-tained as a colourless crystalline mass from chloroform–meth-
anol (19:5) eluents. Its IR spectrum showed characteristic
absorption bands for hydroxyl group (3350 cm1) and unsatu-
ration (1640 cm1). On the basis of FAB mass and 13C NMR
spectra, the molecular ion peak of 5 was determined at m/z 365
[M+H]+ corresponding to the molecular formula of a mono-
cyclic unsaturated sesterterpenol, C25H49O. The
1H NMR
spectrum of 5 exhibited a one-proton multiplet at d 5.13 that
was assigned to vinylic H-7. A one-proton doublet at d 3.52
(J= 5.1, 8.5 Hz) was ascribed to the a-oriented carbinol H-4
proton. Two three-proton broad singlets at d 1.23 and 1.21
were attributed to the tertiary C-21 and C-22 methyl protons,
respectively. Five three-proton doublets at d 1.11 (J= 6.1 Hz),
0.96 (J= 6.3 Hz), 0.93 (J= 6.0 Hz), 0.88 (J= 6.5 Hz) and
0.83 (J= 6.1 Hz) were accounted for the secondary C-20, C-
23, C-24, C-19 and C-25 methyl protons, respectively. The
remaining methine and methylene protons appeared from d
2.50 to 1.25. The 13C NMR spectrum of 5 displayed important
signals for vinylic carbons at d 140.63 (C-6) and 127.13 (C-7),
carbinol carbon at d 71.08 (C-4) and methyl carbons between d
27.16 and 15.02. The 1H–1H COSY spectrum of 5 showed cor-
relations of H-4 with H2-2, H2-3 and Me-21; H-7 with H2-8,
H2-9, H-1, Me-20 and Me-22; and H-18 with H2-17, Me-19and Me-25. The HMBC spectrum of 5 exhibited interactions
of C-4 with H2-3, H2-2 and Me-21; C-6 with H-1, Me-20,
Me-21, Me-22, H-7 and H2-8; and C-18 with H2-17, H2-16,
Me-19 and Me-25. On the basis of these evidences the structure
of 5 was formulated as 1b,4a,4b-trimethyl-6-(10,14,18-trimeth-
























Compounds 2, 6 and 7 are the known phytoconstituents
that were identiﬁed as continentalic acid (Sharma et al.,























The present work has characterized several chemical com-
pounds from the roots of A. cachemirica. The existing knowl-
edge regarding its phytoconstituents may be increased by the
present phytochemical investigation which may be responsible
for medicinal property of the plant and may be used as chro-
matographic marker of the drug.Acknowledgement
The authors are thankful to the Head, Sophisticated Analyti-
cal Instrumentation Facility (SAIF), Central Drug Research
Institute, Lucknow, for recording mass spectra of the
compounds.
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